Phibro Animal Health (PAHC) FCF Payout Ratio Growth (3y) (2017 - 2026)
Phibro Animal Health (PAHC) FCF Payout Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -65.59% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.33% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.53% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 56.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.84% |
| Dec 31, 2025 | -81.63% |
| Sep 30, 2025 | 78.49% |
| Jun 30, 2025 | 43.03% |
| Mar 31, 2025 | 28.26% |
| Dec 31, 2024 | -66.54% |
| Sep 30, 2024 | 47.27% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | 75.42% |
| Dec 31, 2023 | 26.96% |
| Sep 30, 2023 | -54.63% |
| Jun 30, 2023 | 71.96% |
| Mar 31, 2023 | -40.22% |
| Dec 31, 2022 | 20.93% |
| Sep 30, 2022 | 30.73% |
| Jun 30, 2022 | 37.97% |
| Mar 31, 2022 | -79.41% |
| Dec 31, 2021 | 8.55% |
| Sep 30, 2021 | -36.58% |
| Jun 30, 2021 | -38.22% |